Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 36,220 | 34,125 | 26,063 | 25,881 | 20,401 |
| Cost of Goods | 1,897 | 1,520 | 1,238 | 12,379 | 1,345 |
| Gross Profit | 34,323 | 32,605 | 24,825 | 13,502 | 19,056 |
| Operating Expenses | -16,926 | 23,810 | 20,920 | 84,920 | 24,763 |
| Operating Income | 52,146 | 9,315 | 4,143 | -71,039 | -5,362 |
| Interest Expense | 1,711 | 1,948 | 2,051 | 2,009 | 1,969 |
| Other Income | -5,631 | 5,299 | -3,069 | 149,954 | 5,414 |
| Pre-tax Income | 44,804 | 12,666 | -977 | 76,906 | -1,917 |
| Income Tax | 6,914 | 501 | -433 | 2,199 | 1,182 |
| Net Income Continuous | 37,890 | 12,165 | -544 | 74,707 | -3,099 |
| Net Income | $37,890 | $12,165 | $-544 | $74,707 | $-3,099 |
| EPS Basic Total Ops | 0.62 | 0.23 | -0.01 | 1.24 | -0.06 |
| EPS Basic Continuous Ops | 0.65 | 0.21 | -0.01 | 1.36 | -0.06 |
| EPS Diluted Total Ops | 0.60 | 0.21 | -0.01 | 1.21 | -0.06 |
| EPS Diluted Continuous Ops | 0.63 | 0.19 | -0.01 | 1.33 | -0.06 |
| EPS Diluted Before Non-Recurring Items | N/A | 1.16 | -0.01 | -0.06 | -0.06 |
| EBITDA(a) | $51,890 | $8,820 | $3,324 | $-11,433 | $-4,018 |